Bob Enck

Chairman & President at ProtonDx

Bob Enck is an accomplished business leader with extensive experience in the healthcare and investment sectors. Currently serving as Chairman and President of ProtonDx since July 2021, Bob has played a pivotal role in advancing molecular diagnostics. Additionally, Bob is Chairman of the US Gold Opportunity Fund, LP, which provides investors a tax-efficient vehicle for gold bullion investment, while aiding economically challenged communities. As Principal and Founder of Ampersand Investment Management, Bob has been instrumental in managing investments since 2019. Bob's previous experience includes significant leadership roles such as CEO of Equinox Funds, Senior Managing Director at The Hermes Group, and CEO at Beansprout Networks, where Bob successfully led a venture-funded healthcare services firm to profitability. Bob's educational background includes a Bachelor of Science in Natural Sciences from the College of Saint Benedict and Saint John's University and an MBA from the University of St. Thomas.

Links

Previous companies

Bristol-Myers Squibb logo

Org chart

Sign up to view 3 direct reports

Get started